Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Anti-snoring treatment industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends (USD Miliion & Units)
2.1.2 Device trends (USD Miliion & Units)
2.1.3 Distribution channel trends (USD Miliion & Units)
2.1.4 Regional trends (USD Miliion & Units)
Chapter 3 Anti-snoring Treatment Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising geriatric and obese people
3.2.1.2 Growing cigarette and alcohol consumption
3.2.1.3 Technological advancement in anti-snoring devices
3.2.1.4 Increasing prevalence of sleep disorder
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of devices
3.2.2.2 Lack of reimbursement policies
3.3 Growth potential analysis
3.3.1 By device
3.3.2 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Competitive dashboard, 2021
4.3 Company matrix analysis, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Anti-snoring Treatment Market, By Device
5.1 Key segment trends
5.2 Mandible advancement devices
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 - 2032 (Units)
5.3 Tongue stabilizing devices
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 - 2032 (Units)
5.4 Nasal devices
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Market estimates and forecast, 2018 - 2032 (Units)
5.5 Continuous positive airway pressure devices
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5.2 Market estimates and forecast, 2018 - 2032 (Units)
5.6 Chin straps
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6.2 Market estimates and forecast, 2018 - 2032 (Units)
5.7 Others
5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 6 Anti-snoring Treatment Market, By Distribution channel
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.2 Market estimates and forecast, 2018 - 2032 (Units)
6.3 Clinics
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.2 Market estimates and forecast, 2018 - 2032 (Units)
6.4 Retail pharmacies
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4.2 Market estimates and forecast, 2018 - 2032 (Units)
6.5 E-commerce
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5.2 Market estimates and forecast, 2018 - 2032 (Units)
6.6 Others
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6.2 Market estimates and forecast, 2018 - 2032 (Units)
Chapter 7 Anti-snoring Treatment Market Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Russia
7.3.7 Poland
7.3.8 Switzerland
7.3.9 The Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 India
7.4.3 Japan
7.4.4 Australia
7.4.5 South Korea
7.4.6 Thailand
7.4.7 Indonesia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Israel
Chapter 8 Company Profiles
8.1 Apnea Science
8.2 SomnoMed
8.3 Koninklijke Philips
8.4 The Pure Sleep Company
8.5 Airway Management Inc
8.6 Tomed GmBH
8.7 Meditas
8.8 GlaxoSmithKline Plc
8.9 Fisher & Paykel Healthcare
8.10 ResMed
8.11 Theravent (Foundation Consumer Healthcare)
8.12 The Pure Sleep Co (Sleep Science Partners, Inc)
8.13 Vyaire Medical
